SNCA and Parkinson disease: They identified a negative spatial co-expression between SNCA and interferon-gamma signaling genes in the normal brain and a positive co-expression in post-mortem samples from Parkinson’s patients, suggesting an immune-modulatory role of SNCA that may provide insight into neurodegeneration.